We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

246 hedge funds and large institutions have $1.79B invested in Dynavax Technologies in 2023 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 74 increasing their positions, 83 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

169% more call options, than puts

Call options by funds: $6.43M | Put options by funds: $2.39M

128% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 18

9% more funds holding

Funds holding: 225246 (+21)

1.26% more ownership

Funds ownership: 97.84%99.1% (+1.3%)

4% less capital invested

Capital invested by funds: $1.86B → $1.79B (-$70.7M)

11% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 83

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
246
Holders Change
+21
Holders Change %
+9.33%
% of All Funds
3.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
41
Increased
74
Reduced
83
Closed
18
Calls
$6.43M
Puts
$2.39M
Net Calls
+$4.05M
Net Calls Change
-$7.17M
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$10.3M -$7.63K -549 -0.1%
MMA
27
Mizuho Markets Americas
New York
$10.2M +$332K +23,900 +3%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$10.1M -$9.16M -659,337 -48%
Nomura Holdings
29
Nomura Holdings
Japan
$9.31M +$1.14M +82,298 +14%
Millennium Management
30
Millennium Management
New York
$9.2M +$9.15M +658,433 New
UBS Group
31
UBS Group
Switzerland
$9.06M +$7.29M +525,012 +427%
JP Morgan Chase
32
JP Morgan Chase
New York
$8.97M +$5.29M +381,124 +146%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$7.55M +$885K +63,685 +13%
BC
34
Burney Company
Virginia
$7.49M +$205K +14,758 +3%
PCM
35
Peregrine Capital Management
Minnesota
$7.37M -$1.26M -90,916 -15%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$7.13M -$4.3M -309,353 -38%
GLA
37
Great Lakes Advisors
Illinois
$6.83M -$3.59M -258,231 -35%
Citigroup
38
Citigroup
New York
$6.61M +$3.03M +218,124 +86%
PAM
39
Panagora Asset Management
Massachusetts
$6.3M +$821K +59,100 +15%
Bank of America
40
Bank of America
North Carolina
$6.24M -$532K -38,306 -8%
RA
41
Royce & Associates
New York
$6.01M -$99.6K -7,171 -2%
OAM
42
Oberweis Asset Management
Illinois
$5.84M +$447K +32,200 +8%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$5.78M +$1.09M +78,824 +24%
Barclays
44
Barclays
United Kingdom
$5.63M +$1.73M +124,268 +45%
Ameriprise
45
Ameriprise
Minnesota
$5.47M -$360K -25,893 -6%
Point72 Asset Management
46
Point72 Asset Management
Connecticut
$5.33M -$1.97M -141,900 -27%
Legal & General Group
47
Legal & General Group
United Kingdom
$5.12M +$34.7K +2,501 +0.7%
Nordea Investment Management
48
Nordea Investment Management
Sweden
$4.49M -$101K -7,255 -2%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$4.25M -$40.8K -2,935 -1%
Swedbank
50
Swedbank
Sweden
$4.21M

DVAX Hedge Fund Activity: Q4 2023 in Review

246 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q4 2023, worth a combined $1.79B — down 3.8% from $1.86B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new DVAX positions and 18 closed out — a net gain of 23 holders — while 74 added to existing stakes and 83 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $41.2M. The largest seller was Citadel Advisors, cutting an estimated $32.6M.

  • 246 institutional investors held Dynavax Technologies (DVAX) as of Q4 2023, up from 225 in Q3 2023.
  • Funds reported $1.79B of Dynavax Technologies stock for Q4 2023, down 3.8% quarter-over-quarter.
  • 41 funds opened new Dynavax Technologies positions in Q4 2023 and 18 closed out, a net change of +23 holders.
  • The largest Dynavax Technologies buyer in Q4 2023 was Morgan Stanley, an estimated $41.2M added.
  • The largest Dynavax Technologies seller in Q4 2023 was Citadel Advisors, an estimated $32.6M sold.

Based on aggregated 13F filings for Q4 2023.